Bio-Rad Laboratories BIO
NYSE BIO
$382.40 +3.37 (+0.89%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Gross Margin Growth (3y) (2012 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 24.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 151.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1,613.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 419.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 39.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -212.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -10.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 373.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 664.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -32.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.00
Mar 31, 2026 -129.00
Dec 31, 2025 -458.00
Sep 30, 2025 -214.00
Jun 30, 2025 -416.00
Mar 31, 2025 -523.00
Dec 31, 2024 -334.00
Sep 30, 2024 -365.00
Jun 30, 2024 -41.00
Mar 31, 2024 -175.00
Dec 31, 2023 -448.00
Sep 30, 2023 -363.00
Jun 30, 2023 -135.00
Mar 31, 2023 -198.00
Dec 31, 2022 147.00
Sep 30, 2022 -3.00
Jun 30, 2022 340.00
Mar 31, 2022 122.00
Dec 31, 2021 66.00
Sep 30, 2021 584.00